Schroder Investment Management Group Portfolio holdings
AUM
$118B
1-Year Return
26.33%
This Quarter Return
+16.28%
1 Year Return
+26.33%
3 Year Return
+110.68%
5 Year Return
+193.29%
10 Year Return
+454%
AUM
$118B
AUM Growth
+$19.3B
(+19%)
Cap. Flow
+$7.38B
Cap. Flow
% of AUM
6.24%
Top 10 Holdings %
Top 10 Hldgs %
30.96%
Holding
1,256
New
68
Increased
498
Reduced
525
Closed
100
Top Buys
| 1 |
Microsoft
MSFT
|
$1.1B |
| 2 |
Monster Beverage
MNST
|
$447M |
| 3 |
NVIDIA
NVDA
|
$425M |
| 4 |
Netflix
NFLX
|
$363M |
| 5 |
Colgate-Palmolive
CL
|
$343M |
Top Sells
| 1 |
Trip.com Group
TCOM
|
$462M |
| 2 |
lululemon athletica
LULU
|
$353M |
| 3 |
UnitedHealth
UNH
|
$293M |
| 4 |
Spotify
SPOT
|
$260M |
| 5 |
Procter & Gamble
PG
|
$201M |
Sector Composition
| 1 | Technology | 30.09% |
| 2 | Communication Services | 13.6% |
| 3 | Financials | 13.17% |
| 4 | Consumer Discretionary | 11.14% |
| 5 | Healthcare | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RERE
901
ATRenew
RERE
$968M
| $1.75M | ﹤0.01% |
530,179
-57,006
| -10% | -$189K |
|
902
Rio Tinto
RIO
$104B
| $1.75M | ﹤0.01% |
30,057
-1,658
| -5% | -$96.7K |
|
903
Biogen
BIIB
$20.6B
| $1.73M | ﹤0.01% |
13,767
-46,568
| -77% | -$5.85M |
|
904
CAVA Group
CAVA
$7.73B
| $1.7M | ﹤0.01% |
20,146
-33,056
| -62% | -$2.78M |
|
905
Dollar General
DG
$24.1B
| $1.69M | ﹤0.01% |
14,748
+1,214
| +9% | +$139K |
|
906
StoneCo
STNE
$4.63B
| $1.67M | ﹤0.01% |
+104,216
| New | +$1.67M |
|
907
CDW
CDW
$22.2B
| $1.67M | ﹤0.01% |
9,358
-163
| -2% | -$29.1K |
|
908
Teradyne
TER
$19.1B
| $1.66M | ﹤0.01% |
18,514
+886
| +5% | +$79.7K |
|
909
Crocs
CROX
$4.72B
| $1.65M | ﹤0.01% |
16,333
+8,702
| +114% | +$881K |
|
910
Kellanova
K
$27.8B
| $1.63M | ﹤0.01% |
20,547
-2,781
| -12% | -$221K |
|
911
Novo Nordisk
NVO
$245B
| $1.63M | ﹤0.01% |
23,624
+9
| +0% | +$621 |
|
912
Comerica
CMA
$8.85B
| $1.61M | ﹤0.01% |
27,119
+21,754
| +405% | +$1.29M |
|
913
DigitalOcean
DOCN
$2.98B
| $1.55M | ﹤0.01% |
+54,359
| New | +$1.55M |
|
914
Iovance Biotherapeutics
IOVA
$901M
| $1.54M | ﹤0.01% |
897,354
+394,791
| +79% | +$679K |
|
915
SPDR Portfolio High Yield Bond ETF
SPHY
$9.11B
| $1.54M | ﹤0.01% |
+64,811
| New | +$1.54M |
|
916
Insulet
PODD
$24.5B
| $1.53M | ﹤0.01% |
4,874
+1,147
| +31% | +$360K |
|
|
CMPS
917
Compass Pathways
CMPS
$493M
| $1.53M | ﹤0.01% |
+544,721
| New | +$1.53M |
|
918
Steris
STE
$24.2B
| $1.52M | ﹤0.01% |
6,345
-1,382
| -18% | -$332K |
|
919
Taylor Morrison
TMHC
$7.1B
| $1.5M | ﹤0.01% |
24,431
-8,972
| -27% | -$551K |
|
|
ZBIO
920
Zenas BioPharma, Inc. Common Stock
ZBIO
$864M
| $1.48M | ﹤0.01% |
154,916
-9,119
| -6% | -$87.4K |
|
921
Church & Dwight Co
CHD
$23.3B
| $1.47M | ﹤0.01% |
15,326
-414,417
| -96% | -$39.8M |
|
922
Western Alliance Bancorporation
WAL
$10B
| $1.47M | ﹤0.01% |
18,889
+15,153
| +406% | +$1.18M |
|
923
Tyler Technologies
TYL
$24.2B
| $1.45M | ﹤0.01% |
2,451
+150
| +7% | +$88.9K |
|
924
Vanda Pharmaceuticals
VNDA
$272M
| $1.45M | ﹤0.01% |
307,176
-359,285
| -54% | -$1.7M |
|
925
REV Group
REVG
$3.05B
| $1.44M | ﹤0.01% |
+30,295
| New | +$1.44M |
|